Dicerna Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch DRNA and buy or sell other stocks, ETFs, and their options commission-free!

About DRNA

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.

CEO

Douglas M. Fambrough, III, PhD

CEODouglas M. Fambrough, III, PhD

Employees

—

Employees—

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2006

Founded2006

Employees

—

Employees—

DRNA Key Statistics

Market cap

2.98B

Market cap2.98B

Price-Earnings ratio

-23.44

Price-Earnings ratio-23.44

Dividend yield

—

Dividend yield—

Average volume

3.20M

Average volume3.20M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$40.14

52 Week high$40.14

52 Week low

$19.06

52 Week low$19.06

People also own

Based on the portfolios of people who own DRNA. This list is generated using Robinhood data, and it’s not a recommendation.